Published in Ophthalmologe on February 01, 2004
Influence of different purification techniques on triamcinolone yield and particle size spectrum. Graefes Arch Clin Exp Ophthalmol (2006) 1.25
Bevacizumab in retinal vein occlusion-results of a prospective case series. Graefes Arch Clin Exp Ophthalmol (2007) 1.22
[Cystoid macular edema in uveitis]. Ophthalmologe (2005) 0.96
Intravitreal bevacizumab vs. sham treatment in acute branch retinal vein occlusion with macular edema: results at 3 months (Report 1). Graefes Arch Clin Exp Ophthalmol (2010) 0.88
[Intravitreal injection. Monitoring to avoid postoperative complications]. Ophthalmologe (2008) 0.81
The combination of intravitreal triamcinolone and phacoemulsification surgery in patients with diabeticfoveal oedema and cataract. BMC Ophthalmol (2005) 0.80
Associated factors and treatment outcome of presumed noninfectious endophthalmitis occurring after intravitreal triamcinolone acetonide injection. Graefes Arch Clin Exp Ophthalmol (2012) 0.79
Triamcinolone acetonide and anecortave acetate do not stimulate uveal melanoma cell growth. Mol Vis (2008) 0.78
[Optic atrophy subsequent to epiretinal triamcinolone deposits in an eye following inner limiting membrane peeling]. Ophthalmologe (2008) 0.77
Effect of intravitreal dexamethasone implant on retinal and choroidal thickness in refractory diabetic macular oedema after multiple anti-VEGF injections. Eye (Lond) (2016) 0.76
Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies. J Control Release (2017) 0.75
[Classification of biomedical research reports as a reference for evidence-based medicine in ophthalmology. A survey considering as example the journal Der Ophthalmologe]. Ophthalmologe (2005) 0.75
[Endophthalmitis after repeated bevacizumab injections]. Ophthalmologe (2009) 0.75
Examination of purification methods and development of intravitreal injection of triamcinolone acetonide. Jpn J Ophthalmol (2005) 0.75
Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group. Arch Ophthalmol (1995) 10.80
Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol (2003) 4.78
Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina (2000) 2.87
Noninfectious endophthalmitis associated with intravitreal triamcinolone injection. Arch Ophthalmol (2003) 2.77
Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis. Clin Experiment Ophthalmol (2001) 2.76
Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology (2003) 2.61
A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results. Arch Ophthalmol (2003) 2.56
Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol (2003) 2.39
Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol (2003) 2.25
Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up. Aust N Z J Ophthalmol (1998) 2.20
Central serous chorioretinopathy in endogenous hypercortisolism. Arch Ophthalmol (1993) 2.20
An anaphylactic reaction to intra-articular triamcinolone: a case report and review of the literature. Ann Allergy Asthma Immunol (2003) 2.05
Intravitreal triamcinolone and elevated intraocular pressure. Aust N Z J Ophthalmol (1999) 1.91
Trends in cataract surgery and postoperative endophthalmitis in Western Australia (1980-1998): the Endophthalmitis Population Study of Western Australia. Clin Experiment Ophthalmol (2003) 1.68
Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina (2003) 1.60
Postoperative endophthalmitis: establishment and results of a national registry. J Cataract Refract Surg (2003) 1.54
The clearance of intravitreal triamcinolone acetonide. Am J Ophthalmol (1982) 1.52
Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown. Graefes Arch Clin Exp Ophthalmol (2002) 1.52
Nuclear sclerotic cataract after vitrectomy in patients younger than 50 years of age. Ophthalmology (1995) 1.39
Intravitreal triamcinolone acetonide for exudative age related macular degeneration. Br J Ophthalmol (2003) 1.36
Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids. Ophthalmology (1997) 1.33
Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations. Am J Ophthalmol (1986) 1.29
Pseudo-endophthalmitis after intravitreal injection of triamcinolone. Br J Ophthalmol (2003) 1.27
Endophthalmitis caused by Mycobacterium chelonae abscessus after intravitreal injection of triamcinolone. Arch Ophthalmol (2003) 1.26
Treatment of cytomegalovirus retinitis with intravitreal ganciclovir. Long-term results. Ophthalmology (1989) 1.25
Secondary chronic open-angle glaucoma after intravitreal triamcinolone acetonide. Arch Ophthalmol (2003) 1.23
Managing cystoid macular edema after cataract surgery. Curr Opin Ophthalmol (2003) 1.17
The toxic and stress responses of cultured human retinal pigment epithelium (ARPE19) and human glial cells (SVG) in the presence of triamcinolone. Invest Ophthalmol Vis Sci (2003) 1.16
The effect of intravitreal triamcinolone acetonide on intraocular pressure. Ophthalmic Surg Lasers Imaging (2003) 1.09
Acute-onset postoperative endophthalmitis: review of incidence and visual outcomes (1995-2001). Ophthalmic Surg Lasers (2002) 1.05
Accidental subretinal injection of triamcinolone acetonide. Ophthalmic Surg Lasers (1998) 1.05
Submacular deposition of triamcinolone acetonide after triamcinolone-assisted vitrectomy. Am J Ophthalmol (2003) 0.95
Conjunctival ulceration following triamcinolone injection. Am J Ophthalmol (2003) 0.92
Retinal toxicity of triamcinolone acetonide in silicone-filled eyes. Ophthalmic Surg Lasers (2001) 0.91
Intravitreal triamcinolone and endophthalmitis. Am J Ophthalmol (2003) 0.86
Anaphylaxis induced by the carboxymethylcellulose component of injectable triamcinolone acetonide suspension (Kenalog). Ann Allergy Asthma Immunol (1995) 0.85
Treatment of cytomegalovirus retinitis in AIDS patients using intravitreal injections of highly concentrated ganciclovir. Ophthalmologica (1996) 0.84
Reactivation of CMV retinitis after treatment with subtenon corticosteroids for immune recovery uveitis in a patient with AIDS. Scand J Infect Dis (2002) 0.84
Six cases of central serous choroidopathy induced by systemic corticosteroid therapy. Doc Ophthalmol (1985) 0.82
Allergic reaction to intralesional triamcinolone acetonide: a case report. Arch Dermatol (1995) 0.81
In vivo reactivation of latent murine cytomegalovirus in the eye by immunosuppressive treatment. Invest Ophthalmol Vis Sci (1990) 0.79
[Readaptation time after photo-stress in normal subjects and glaucoma patients]. Ophthalmologe (2003) 0.78
Hypersensitivity reaction to intravitreal clindamycin therapy. Clin Experiment Ophthalmol (2002) 0.78
Optic disk cup filled with triamcinolone. Retina (2002) 0.77
[Effects of intravitreal steroid injection on rabbit eye]. Nippon Ganka Gakkai Zasshi (1989) 0.76
Anaphylactic reaction to intravitreal cefazolin. Retina (1994) 0.75
Retinal side-effects of sildenafil. Lancet (1999) 2.40
[Recommendation for the implementation of intravitreal injections--statement of the German Retina Society, the German Society of Ophthalmology (DOG) and the German Professional Association of Ophthalmologists (BVA)]. Klin Monbl Augenheilkd (2005) 1.66
Polypoidal choroidal vasculopathy pattern in age-related macular degeneration: a clinicopathologic correlation. Retina (2000) 1.46
Transplantation of autologous iris pigment epithelium to the subretinal space in rabbits. Transplantation (1999) 1.45
Surgical treatment of peripapillary choroidal neovascularisation. Br J Ophthalmol (2007) 1.44
Extraocular surgery for implantation of an active subretinal visual prosthesis with external connections: feasibility and outcome in seven patients. Br J Ophthalmol (2008) 1.39
Implantation of the multifocal ReSTOR apodised diffractive intraocular lens in adult anisometropic patients with mild to moderate amblyopia. Br J Ophthalmol (2009) 1.39
Antiproliferative and cytotoxic properties of bevacizumab on different ocular cells. Br J Ophthalmol (2006) 1.24
Clinicopathological correlation in exudative age related macular degeneration: histological differentiation between classic and occult choroidal neovascularisation. Br J Ophthalmol (2000) 1.23
[Intravitreal bevacizumab for neovascular age-related macular degeneration]. Ophthalmologe (2006) 1.20
[Bevacizumab for treatment of macular edema secondary to retinal vein occlusion]. Ophthalmologe (2006) 1.19
Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2006) 1.16
Influence of membrane differential filtration on the natural course of age-related macular degeneration: a randomized trial. Retina (2000) 1.15
Oxidation causes melanin fluorescence. Invest Ophthalmol Vis Sci (2001) 1.11
Scleral buckling versus primary vitrectomy in rhegmatogenous retinal detachment (SPR Study): design issues and implications. SPR Study report no. 1. Graefes Arch Clin Exp Ophthalmol (2001) 1.09
Combined treatment of a juxtapapillary retinal capillary haemangioma with intravitreal bevacizumab and photodynamic therapy. Eye (Lond) (2007) 1.08
Clinicopathological correlation of retinal pigment epithelial tears in exudative age related macular degeneration: pretear, tear, and scarred tear. Br J Ophthalmol (2001) 1.08
Retinal pigment epithelial tears after single administration of intravitreal bevacizumab for neovascular age-related macular degeneration. Eye (Lond) (2008) 1.07
Partial deletions of the long and short arm of chromosome 3 point to two tumor suppressor genes in uveal melanoma. Cancer Res (2001) 1.06
Successful long-term implantation of electrically inactive epiretinal microelectrode arrays in rabbits. Retina (1999) 1.04
[Pathophysiology of cataract formation after vitrectomy]. Klin Monbl Augenheilkd (2010) 1.04
Subretinally transplanted embryonic stem cells rescue photoreceptor cells from degeneration in the RCS rats. Cell Transplant (2001) 1.02
Effects of bevacizumab on retinal function in isolated vertebrate retina. Br J Ophthalmol (2006) 1.02
Choroidal neovascularization in retinochoroidal coloboma: thermal laser treatment achieves long-term stabilization of visual acuity. Eye (Lond) (2005) 1.00
Retinectomy for treatment of intractable glaucoma: long term results. Br J Ophthalmol (2003) 0.98
Autologous platelet treatment for optic disc pit associated with persistent macular detachment. Graefes Arch Clin Exp Ophthalmol (1998) 0.98
Clinicopathological findings of choroidal neovascularisation following verteporfin photodynamic therapy. Br J Ophthalmol (2004) 0.97
Transplantation of autologous iris pigment epithelium after removal of choroidal neovascular membranes. Arch Ophthalmol (2000) 0.96
Treatment of chronic ocular hypotony with intraocular application of sodium hyaluronate. Br J Ophthalmol (2008) 0.96
Reproducibility of circadian retinal and optic nerve head blood flow measurements by Heidelberg retina flowmetry. Br J Ophthalmol (2004) 0.93
Clinicopathological correlation of deep retinal vascular anomalous complex in age related macular degeneration. Br J Ophthalmol (2000) 0.93
Long-term fluctuations of the normalised rim/disc area ratio quotient in normal eyes. Graefes Arch Clin Exp Ophthalmol (1999) 0.92
The artificial iris diaphragm for vitreoretinal silicone oil surgery. Retina (1997) 0.91
Clinicopathological correlation in exudative age-related macular degeneration: recurrent choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol (2001) 0.89
[Silicone oils in retinal surgery ]. Ophthalmologe (2000) 0.88
[Injector implantation of a scleral-fixated intraocular lens]. Ophthalmologe (2006) 0.88
The effects of ranibizumab (Lucentis) on retinal function in isolated perfused vertebrate retina. Br J Ophthalmol (2009) 0.87
[Current strategies for macular hole surgery in Germany, Austria and Switzerland]. Ophthalmologe (2006) 0.87
[New developments in retinal detachment surgery]. Ophthalmologe (2008) 0.86
Laceration of the eye with a fishing hook. Br J Ophthalmol (1999) 0.85
Detection of mRNA for proteins involved in retinol metabolism in iris pigment epithelium. Graefes Arch Clin Exp Ophthalmol (1999) 0.85
[Refractive changes after Descemet membrane endothelial keratoplasty]. Ophthalmologe (2014) 0.84
Phagocytosis of rod outer segments by human iris pigment epithelial cells in vitro. Graefes Arch Clin Exp Ophthalmol (1998) 0.83
Progressive subretinal fibrosis in a child following hemolytic uremic syndrome. Retina (1999) 0.83
Counterrotation of the globe in macular translocation. Graefes Arch Clin Exp Ophthalmol (2000) 0.82
Coats'-like response in blood-filled senile retinoschisis. Ophthalmologica (2002) 0.82
[Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists: treatment of diabetic maculopathy (April 2013)]. Klin Monbl Augenheilkd (2013) 0.82
Ultimate fate of rod outer segments in the retinal pigment epithelium. Pigment Cell Res (1999) 0.82
[(Side) effects of VEGF inhibition]. Ophthalmologe (2006) 0.82
[Clinical results after Descemet membrane endothelial keratoplasty]. Klin Monbl Augenheilkd (2012) 0.82
[What can blind patients see in daily life with the subretinal Alpha IMS implant? Current overview from the clinical trial in Tübingen]. Ophthalmologe (2012) 0.82
[Subjective and objective outcome following implantation of the apodized diffractive AcrySof ReSTOR]. Ophthalmologe (2007) 0.81
[Corneal staphyloma-anterior chamber agenesia-microphakia syndrome]. Klin Monbl Augenheilkd (2006) 0.81
Clinicopathologic correlation in hemorrhagic age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2002) 0.81
[Pseudohypopyon of cholesterol crystals occurring 16 years after retinal detachment in x-linked retinoschisis]. Klin Monbl Augenheilkd (2001) 0.80
Verteporfin photodynamic therapy induced apoptosis in choroidal neovascular membranes. Br J Ophthalmol (2006) 0.80
Implications of bevacizumab on vascular endothelial growth factor and endostatin in human choroidal neovascularisation. Br J Ophthalmol (2008) 0.80
[Endophthalmitis]. Ophthalmologe (1999) 0.80
Descemet's membrane as membranous support in RPE/IPE transplantation. Curr Eye Res (1997) 0.80
Plasminogen in proliferative vitreoretinal disorders. Br J Ophthalmol (1997) 0.80
Does intravitreal injection of bevacizumab have an effect on the blood-aqueus barrier function? Br J Ophthalmol (2006) 0.79
[Macular translocation with 360 degree retinotomy in the treatment if exudative macular degeneration. Functional and angiographic results]. Ophthalmologe (2002) 0.79
Electrophysiological changes after 360 degrees retinotomy and macular translocation for subfoveal choroidal neovascularisation in age related macular degeneration. Br J Ophthalmol (2001) 0.79
[The influence of the HIV pandemic on the incidence of malignant ocular tumours in Southern Malawi (Blantyre)]. Ophthalmologe (2009) 0.79
[Late recurrence of donor contamination-related candida glabrata endophthalmitis following penetrating keratoplasty]. Klin Monbl Augenheilkd (2009) 0.79
Candida albicans endophthalmitis after anabolic steroid abuse. Lancet (1995) 0.79
[Therapy of myopic choroidal neovascularization]. Ophthalmologe (2012) 0.79
Intravitreal daunomycin induces multidrug resistance in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci (1998) 0.79
[Visual prognosis and patient selection]. Ophthalmologe (2002) 0.78
Characterisation of novel uveal melanoma cell lines under serum-free conditions. Graefes Arch Clin Exp Ophthalmol (2013) 0.78
CD 95 expression in traumatic proliferative vitreoretinopathy: a target for the induction of apoptosis. Ger J Ophthalmol (1996) 0.78
Clinicopathological correlation of choroidal neovascularization after external beam radiotherapy in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2003) 0.78
Late onset of Leber's hereditary optic neuropathy in HIV infection. Br J Ophthalmol (1999) 0.78
[Effects of transcorneal electrical stimulation in patients with Stargardt's disease]. Ophthalmologe (2013) 0.78
[Vitreous body and retinal vein occlusion]. Ophthalmologe (2014) 0.78
[Effect of timolol on central corneal thickness and endothelial cell density]. Klin Monbl Augenheilkd (2006) 0.78
Dulbecco's Modified Eagle Medium is neuroprotective when compared to standard vitrectomy irrigation solution. Graefes Arch Clin Exp Ophthalmol (2013) 0.78
[Vitreoretinal surgery in the treatment of neovascular glaucoma]. Klin Monbl Augenheilkd (1999) 0.78
Primary non familial amyloidosis of the vitreous and subretinal amyloid bodies. Int Ophthalmol (1999) 0.78
[Clinical results after cataract surgery in patients with Behçet's disease]. Klin Monbl Augenheilkd (2011) 0.78
[Significance of postoperative face-down positioning after surgery for idiopathic macular holes: consecutive case-control study]. Klin Monbl Augenheilkd (2000) 0.78
[Intravitreal injections of medications in Germany. Contract situation and legal conditions]. Ophthalmologe (2009) 0.77
External beam radiation in patients suffering from exudative age-related macular degeneration. A matched-pairs study and 1-year clinical follow-up. Graefes Arch Clin Exp Ophthalmol (1998) 0.77
[Chronic central serous chorioretinopathy (cCSC): differential diagnosis to choroidal neovascularisation (CNV) secondary to age-related macular degeneration (AMD)]. Klin Monbl Augenheilkd (2012) 0.77
[About the frequency of excessive epithelial basement membrane thickening in keratoconus]. Klin Monbl Augenheilkd (2006) 0.77
Clinical efficacy of haemorheological treatment using plasma exchange, selective adsorption and membrane differential filtration in maculopathy, retinal vein occlusion and uveal effusion syndrome. Transfus Sci (1996) 0.77
A new DTL-electrode holder for recording of electroretinograms in animals. J Neurosci Methods (2010) 0.77